These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28848346)

  • 1. Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes.
    Yuan ZX; Jia L; Lim LY; Lin JC; Shu G; Zhao L; Ye G; Liang XX; Ji H; Fu HL
    Int J Nanomedicine; 2017; 12():5673-5686. PubMed ID: 28848346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis.
    Morimoto K; Kondo M; Kawahara K; Ushijima H; Tomino Y; Miyajima M; Kimura J
    Pharm Res; 2007 May; 24(5):946-54. PubMed ID: 17372685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin.
    Yuan ZX; Wu XJ; Mo J; Wang YL; Xu CQ; Lim LY
    Eur J Pharm Biopharm; 2015 Aug; 94():363-71. PubMed ID: 26117184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide.
    Cai XJ; Fei WD; Xu YY; Xu H; Yang GY; Cao JW; Ni JJ; Wang Z
    Drug Deliv Transl Res; 2020 Feb; 10(1):93-107. PubMed ID: 31418132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization.
    Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C
    Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.
    Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X
    Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide.
    Zheng Q; Gong T; Sun X; Zhang ZR
    Arch Pharm Res; 2006 Dec; 29(12):1164-70. PubMed ID: 17225468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide.
    Tian T; Song Y; Li K; Sun Y; Wang Q
    Mol Pharm; 2018 Feb; 15(2):560-570. PubMed ID: 29307194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy of rheumatoid arthritis via macrophage repolarization.
    Zhou X; Huang D; Wang R; Wu M; Zhu L; Peng W; Tu H; Deng X; Zhu H; Zhang Z; Wang X; Cao X
    Drug Deliv; 2021 Dec; 28(1):2447-2459. PubMed ID: 34766540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis.
    Zhang L; Chang J; Zhao Y; Xu H; Wang T; Li Q; Xing L; Huang J; Wang Y; Liang Q
    Int J Nanomedicine; 2018; 13():2051-2064. PubMed ID: 29670349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model.
    Chen JG; Liu YF; Gao TW
    J Liposome Res; 2010 Dec; 20(4):297-303. PubMed ID: 20102297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cytoprotective Effect of C60 Derivatives in the Self-Microemulsifying Drug Delivery System against Triptolide-Induced Cytotoxicity In Vitro.
    Xu B; Wang Z; Zhang H; Xu X; Tang M; Wang G; Ding Z; Yu R; Ding M; Zhang T; Shi S
    Molecules; 2024 Aug; 29(17):. PubMed ID: 39274920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles.
    Xu L; Chen H; Xu H; Yang X
    Eur J Pharm Biopharm; 2008 Nov; 70(3):741-8. PubMed ID: 18761405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis.
    Zhang W; Lu C; Liu Z; Yang D; Chen S; Cha A; Wu Z; Lu A
    Planta Med; 2007 Apr; 73(4):336-40. PubMed ID: 17354165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
    Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
    Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential binding of polyethylene glycol-coated liposomes containing a novel cationic lipid, TRX-20, to human subendthelial cells via chondroitin sulfate.
    Harigai T; Kondo M; Isozaki M; Kasukawa H; Hagiwara H; Uchiyama H; Kimura J
    Pharm Res; 2001 Sep; 18(9):1284-90. PubMed ID: 11683241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas.
    Li X; Mao Y; Li K; Shi T; Yao H; Yao J; Wang S
    Drug Deliv; 2016 May; 23(4):1344-54. PubMed ID: 25853479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.
    Mei Z; Li X; Wu Q; Hu S; Yang X
    Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury.
    Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J
    Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
    Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
    Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.